Ticker Details
ResMed Inc. ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.
IPO Date:	June 2, 1995
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$30.18B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.10 | 1.03%
Avg Daily Range (30 D):	$2.30 | 1.08%
Avg Daily Range (90 D):	$2.89 | 1.21%

Institutional Daily Volume
Avg Daily Volume:	.69M
Avg Daily Volume (30 D):	1M
Avg Daily Volume (90 D):	.91M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	32
Avg Trade Size (Sh.) (90 D):	28

Institutional Trades
Total Institutional Trades:	14,984
Avg Institutional Trade:	$6.16M
Avg Institutional Trade (30 D):	$19.9M
Avg Institutional Trade (90 D):	$21.55M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$14.79M
Avg Closing Trade (30 D):	$55.38M
Avg Closing Trade (90 D):	$51.23M
Avg Closing Volume:	96.64K

News

May 5, 2026 @ 5:04 PM 9 Stocks That Could Defy the ’Sell in May a... Source: David Wagner

Apr 29, 2026 @ 8:53 AM Sleep Apnea Devices (Therapeutic, Diagnostic) Mark... Source: Researchandmarkets.Com

Apr 22, 2026 @ 5:00 PM Global Respiratory Care Devices Market to Grow at ... Source: Delveinsight

Mar 10, 2026 @ 6:30 PM 3 Reasons Not to Sleep on ResMed Stock Source: Selena Maranjian

Feb 24, 2026 @ 12:00 PM Anti-snoring Devices Market Competitive Landscape ... Source: Researchandmarkets.Com

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$10.41	$2.74	$2.69
Diluted EPS	$10.37	$2.74	$2.68
Revenue	$5.54B	$1.43B	$1.42B
Gross Profit	$3.41B	$890.98M	$878.72M
Net Income / Loss	$1.52B	$398.73M	$392.59M
Operating Income / Loss	$1.89B	$499.81M	$491.66M
Cost of Revenue	$2.13B	$540.43M	$544.08M
Net Cash Flow	$727.8M	$243.44M	$33.22M
PE Ratio

Splits
Aug 31, 2010	2:1
Oct 03, 2005	2:1
Apr 03, 2000	2:1